Bernward Zeller

  • Consultant; PhD
 

Publications 2020

Juul-Dam KL, Ommen HB, Nyvold CG, Walter C, Vålerhaugen H, Kairisto V, Abrahamsson J, Alm SJ, Jahnukainen K, Lausen B, Reinhardt D, Zeller B, von Neuhoff N, Fogelstrand L, Hasle H (2020)
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia
Br J Haematol, 190 (2), 198-208
DOI 10.1111/bjh.16560, PubMed 32175599

Østergaard A, Bohnstedt C, Grell K, Degn M, Zeller B, Taskinen M, Hafsteinsdottir S, Björgvinsdóttir H, Heyman M, Hoogerbrugge P, Schmiegelow K, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2020)
Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy
Leukemia
DOI 10.1038/s41375-020-0946-2, PubMed 32623444

Publications 2019

Løhmann DJA, Asdahl PH, Abrahamsson J, Ha SY, Jónsson ÓG, Kaspers GJL, Koskenvuo M, Lausen B, De Moerloose B, Palle J, Zeller B, Hasle H (2019)
Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01
Pediatr Blood Cancer, 66 (6), e27701
DOI 10.1002/pbc.27701, PubMed 30848067

Løhmann DJA, Asdahl PH, Abrahamsson J, Ha SY, Jónsson ÓG, Kaspers GJL, Koskenvuo M, Lausen B, De Moerloose B, Palle J, Zeller B, Sung L, Hasle H (2019)
Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia
Cancer Med, 8 (15), 6634-6643
DOI 10.1002/cam4.2554, PubMed 31532076

Løvvik Juul-Dam K, Guldborg Nyvold C, Vålerhaugen H, Zeller B, Lausen B, Hasle H, Beier Ommen H (2019)
Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference values
Pediatr Blood Cancer, 66 (6), e27671
DOI 10.1002/pbc.27671, PubMed 30900388

Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
Pediatr Blood Cancer, 66 (10), e27910
DOI 10.1002/pbc.27910, PubMed 31264356

Publications 2018

Bager N, Juul-Dam KL, Sandahl JD, Abrahamsson J, Beverloo B, de Bont ESJM, Ha SY, Jahnukainen K, Jónsson ÓG, Kaspers GL, Kovalova Z, Lausen B, De Moerloose B, Noren-Nyström U, Palle J, Saks K, Zeller B, Kjeldsen E, Hasle H (2018)
Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study
Br J Haematol, 183 (4), 618-628
DOI 10.1111/bjh.15587, PubMed 30406946

Espersen ADL, Noren-Nyström U, Abrahamsson J, Ha SY, Pronk CJ, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Zeller B, Palmqvist L, Hasle H (2018)
Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature
Genes Chromosomes Cancer, 57 (7), 359-365
DOI 10.1002/gcc.22538, PubMed 29569294

Germeshausen M, Ancliff P, Estrada J, Metzler M, Ponstingl E, Rütschle H, Schwabe D, Scott RH, Unal S, Wawer A, Zeller B, Ballmaier M (2018)
MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia
Blood Adv, 2 (6), 586-596
DOI 10.1182/bloodadvances.2018016501, PubMed 29540340

Løhmann DJA, Asdahl PH, Abrahamsson J, Ha SY, Jónsson ÓG, Kaspers GJL, Koskenvuo M, Lausen B, De Moerloose B, Palle J, Zeller B, Hasle H (2018)
Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia
Pediatr Blood Cancer, 65 (9), e27231
DOI 10.1002/pbc.27231, PubMed 29781563

Zeller B (2018)
B. Zeller svarer
Tidsskr Nor Laegeforen, 138 (7)
DOI 10.4045/tidsskr.18.0234, PubMed 29663759

Zeller B (2018)
[Some thoughts in the wake of a fatal medication error]
Tidsskr Nor Laegeforen, 138 (4)
DOI 10.4045/tidsskr.18.0031, PubMed 29460591

Zeller B (2018)
Some thoughts in the wake of a fatal error in medication
Tidsskr. Nor. Laegeforen., 138 (4), 325

Publications 2017

Karlsson L, Forestier E, Hasle H, Jahnukainen K, Jónsson ÓG, Lausen B, Norén Nyström U, Palle J, Tierens A, Zeller B, Abrahamsson J (2017)
Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia
Br J Haematol, 178 (4), 592-602
DOI 10.1111/bjh.14720, PubMed 28439893

Støve HK, Sandahl JD, Abrahamsson J, Asdahl PH, Forestier E, Ha SY, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Zeller B, Hasle H (2017)
Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO)
Pediatr Blood Cancer, 64 (12)
DOI 10.1002/pbc.26520, PubMed 28333413

Zeller B, Glosli H, Forestier E, Ha SY, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Hasle H, Abrahamsson J, NOPHO AML working group (2017)
Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 109 /l. The NOPHO experience 1984-2014
Br J Haematol, 178 (3), 448-456
DOI 10.1111/bjh.14692, PubMed 28542715

Publications 2016

Laursen AC, Sandahl JD, Kjeldsen E, Abrahamsson J, Asdahl P, Ha SY, Heldrup J, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Zeller B, Forestier E, Hasle H (2016)
Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study
Genes Chromosomes Cancer, 55 (9), 719-26
DOI 10.1002/gcc.22373, PubMed 27153159

Løhmann DJ, Abrahamsson J, Ha SY, Jónsson ÓG, Koskenvuo M, Lausen B, Palle J, Zeller B, Hasle H (2016)
Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004
Haematologica, 101 (11), 1359-1367
DOI 10.3324/haematol.2016.146175, PubMed 27470605

Panagopoulos I, Gorunova L, Kerndrup G, Spetalen S, Tierens A, Osnes LT, Andersen K, Müller LS, Hellebostad M, Zeller B, Heim S (2016)
Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia-association with young age and myeloid sarcomas?
Exp Hematol Oncol, 5, 8
DOI 10.1186/s40164-016-0037-2, PubMed 26949571

Panagopoulos I, Torkildsen S, Gorunova L, Ulvmoen A, Tierens A, Zeller B, Heim S (2016)
RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report
Oncol Rep, 36 (5), 2481-2488
DOI 10.3892/or.2016.5119, PubMed 27667292

Zeller B (2016)
Pediatrics
Tidsskr. Nor. Laegeforen., 136 (17), 1471

Zeller B, Wesenberg F (2016)
[Child cancer is different]
Tidsskr Nor Laegeforen, 136 (17), 1464-6
DOI 10.4045/tidsskr.16.0336, PubMed 27686208

Publications 2015

Kanellopoulos A, Andersson S, Zeller B, Tamnes CK, Fjell AM, Walhovd KB, Westlye LT, Fosså SD, Ruud E (2015)
Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only
Pediatr Blood Cancer, 63 (1), 133-8
DOI 10.1002/pbc.25690, PubMed 26312396

Klein K, Kaspers G, Harrison CJ, Beverloo HB, Reedijk A, Bongers M, Cloos J, Pession A, Reinhardt D, Zimmerman M, Creutzig U, Dworzak M, Alonzo T, Johnston D, Hirsch B, Zapotocky M, De Moerloose B, Fynn A, Lee V, Taga T, Tawa A, Auvrignon A, Zeller B, Forestier E, Salgado C et al. (2015)
Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group
J Clin Oncol, 33 (36), 4247-58
DOI 10.1200/JCO.2015.61.1947, PubMed 26573082

Munthe-Kaas MC, Tierens A, Bechensteen AG, Zeller B (2015)
Myeloid leukemia of Down syndrome: relation to parvovirus B19 infection and wilms tumor gene (WT1) expression
J Pediatr Hematol Oncol, 37 (1), e67-8
DOI 10.1097/MPH.0000000000000093, PubMed 24390447

Sandahl JD, Kjeldsen E, Abrahamsson J, Ha SY, Heldrup J, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Zeller B, Forestier E, Hasle H (2015)
The applicability of the WHO classification in paediatric AML. A NOPHO-AML study
Br J Haematol, 169 (6), 859-67
DOI 10.1111/bjh.13366, PubMed 25819835

Tamnes CK, Zeller B, Amlien IK, Kanellopoulos A, Andersson S, Due-Tønnessen P, Ruud E, Walhovd KB, Fjell AM (2015)
Cortical surface area and thickness in adult survivors of pediatric acute lymphoblastic leukemia
Pediatr Blood Cancer, 62 (6), 1027-34
DOI 10.1002/pbc.25386, PubMed 25597852

Wennström L, Edslev PW, Abrahamsson J, Nørgaard JM, Fløisand Y, Forestier E, Gustafsson G, Heldrup J, Hovi L, Jahnukainen K, Jonsson OG, Lausen B, Palle J, Zeller B, Holmberg E, Juliusson G, Stockelberg D, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO), Danish Acute Leukemia Group, Swedish Acute Myeloid Leukemia Group (2015)
Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries
Pediatr Blood Cancer, 63 (1), 83-92
DOI 10.1002/pbc.25713, PubMed 26281822

Zeller B (2015)
Life after child cancer
Tidsskr. Nor. Laegeforen., 135 (7), 678

Publications 2014

Raja RA, Schmiegelow K, Albertsen BK, Prunsild K, Zeller B, Vaitkeviciene G, Abrahamsson J, Heyman M, Taskinen M, Harila-Saari A, Kanerva J, Frandsen TL, Nordic Society of Paediatric Haematology and Oncology (NOPHO) group (2014)
Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol
Br J Haematol, 165 (1), 126-33
DOI 10.1111/bjh.12733, PubMed 24428625

Sandahl JD, Kjeldsen E, Abrahamsson J, Ha SY, Heldrup J, Jahnukainen K, Jónsson OG, Lausen B, Palle J, Zeller B, Forestier E, Hasle H (2014)
Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study
Genes Chromosomes Cancer, 53 (8), 667-75
DOI 10.1002/gcc.22177, PubMed 24753324

Zeller B, Loge JH, Kanellopoulos A, Hamre H, Wyller VB, Ruud E (2014)
Chronic fatigue in long-term survivors of childhood lymphomas and leukemia: persistence and associated clinical factors
J Pediatr Hematol Oncol, 36 (6), 438-44
DOI 10.1097/MPH.0000000000000051, PubMed 24276036

Publications 2013

Hamre H, Zeller B, Kanellopoulos A, Kiserud CE, Aakhus S, Lund MB, Loge JH, Fosså SD, Ruud E (2013)
High prevalence of chronic fatigue in adult long-term survivors of acute lymphoblastic leukemia and lymphoma during childhod and adolescence
Journal of Adolescent and Young Adult Oncology, 2, 2-9
PublikaID 172

Hamre H, Zeller B, Kanellopoulos A, Kiserud CE, Aakhus S, Lund MB, Loge JH, Fossa SD, Ruud E (2013)
High Prevalence of Chronic Fatigue in Adult Long-Term Survivors of Acute Lymphoblastic Leukemia and Lymphoma During Childhood and Adolescence
J. Adolesc. Young Adult Oncol., 2 (1), 2-9

Hamre H, Zeller B, Kanellopoulos A, Ruud E, Fosså SD, Loge JH, Aukrust P, Halvorsen B, Mollnes TE, Kiserud CE (2013)
Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma
Brain Behav Immun, 30, 80-7
DOI 10.1016/j.bbi.2013.01.006, PubMed 23333795

Panagopoulos I, Gorunova L, Zeller B, Tierens A, Heim S (2013)
Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia
Oncol Rep, 30 (6), 2587-92
DOI 10.3892/or.2013.2751, PubMed 24068373

Panagopoulos I, Micci F, Thorsen J, Haugom L, Buechner J, Kerndrup G, Tierens A, Zeller B, Heim S (2013)
Fusion of ZMYND8 and RELA genes in acute erythroid leukemia
PLoS One, 8 (5), e63663
DOI 10.1371/journal.pone.0063663, PubMed 23667654

Wareham NE, Heilmann C, Abrahamsson J, Forestier E, Gustafsson B, Ha SY, Heldrup J, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Zeller B, Hasle H (2013)
Outcome of poor response paediatric AML using early SCT
Eur J Haematol, 90 (3), 187-94
DOI 10.1111/ejh.12051, PubMed 23215948

Zeller B, Ruud E, Havard Loge J, Kanellopoulos A, Hamre H, Godang K, Bruun Wyller V (2013)
Chronic fatigue in adult survivors of childhood cancer: associated symptoms, neuroendocrine markers, and autonomic cardiovascular responses
Psychosomatics, 55 (6), 621-9
DOI 10.1016/j.psym.2013.12.005, PubMed 24656688

Zeller B, Tamnes CK, Kanellopoulos A, Amlien IK, Andersson S, Due-Tønnessen P, Fjell AM, Walhovd KB, Westlye LT, Ruud E (2013)
Response to A.A.M. van der Veldt et al
J Clin Oncol, 32 (8), 852-3
DOI 10.1200/JCO.2013.52.5725, PubMed 24220558

Zeller B, Tamnes CK, Kanellopoulos A, Amlien IK, Andersson S, Due-Tønnessen P, Fjell AM, Walhovd KB, Westlye LT, Ruud E (2013)
Reduced neuroanatomic volumes in long-term survivors of childhood acute lymphoblastic leukemia
J Clin Oncol, 31 (17), 2078-85
DOI 10.1200/JCO.2012.47.4031, PubMed 23589559

Publications 2012

Bohnstedt C, Levinsen M, Rosthøj S, Zeller B, Taskinen M, Hafsteinsdottir S, Björgvinsdóttir H, Heyman M, Schmiegelow K, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2012)
Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia
Leukemia, 27 (4), 866-70
DOI 10.1038/leu.2012.325, PubMed 23138181

Hasle H, Abrahamsson J, Forestier E, Ha SY, Heldrup J, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Zeller B, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2012)
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
Blood, 120 (5), 978-84
DOI 10.1182/blood-2012-03-416701, PubMed 22730539

Micci F, Thorsen J, Panagopoulos I, Nyquist KB, Zeller B, Tierens A, Heim S (2012)
High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24)
Leukemia, 27 (4), 980-2
DOI 10.1038/leu.2012.266, PubMed 23032695

Rosthøj S, Rajantie J, Treutiger I, Zeller B, Tedgård U, Henter JI, NOPHO ITP Working Group (2012)
Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort
Acta Paediatr, 101 (7), 761-6
DOI 10.1111/j.1651-2227.2012.02671.x, PubMed 22429281

Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012)
Patient knowledge of late effects of acute lymphoblastic leukaemia
Tidsskr Nor Laegeforen, 132 (18), 2052-5
DOI 10.4045/tidsskr.12.0153, PubMed 23038194

Staffas A, Kanduri M, Hovland R, Rosenquist R, Ommen HB, Abrahamsson J, Forestier E, Jahnukainen K, Jonsson OG, Zeller B, Palle J, Lonnerholm G, Hasle H, Ehrencrona H, Palmqvist L (2012)
High ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia Response
Blood, 119 (4), 1087-1088

Publications 2011

Micci F, Thorsen J, Haugom L, Zeller B, Tierens A, Heim S (2011)
Translocation t(1;16)(p31;q24) rearranging CBFA2T3 is specific for acute erythroid leukemia
Leukemia, 25 (9), 1510-2
DOI 10.1038/leu.2011.100, PubMed 21606959

Nyquist KB, Thorsen J, Zeller B, Haaland A, Trøen G, Heim S, Micci F (2011)
Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12)
Cancer Genet, 204 (3), 147-52
DOI 10.1016/j.cancergen.2011.01.003, PubMed 21504714

Staffas A, Kanduri M, Hovland R, Rosenquist R, Ommen HB, Abrahamsson J, Forestier E, Jahnukainen K, Jónsson ÓG, Zeller B, Palle J, Lönnerholm G, Hasle H, Palmqvist L, Ehrencrona H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2011)
Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
Blood, 118 (22), 5905-13
DOI 10.1182/blood-2011-05-353185, PubMed 21967978

Zeller B, Bechensteen AG (2011)
Immunological thrombo-cytopenia in children
Tidsskr Nor Laegeforen, 131 (1), 13
DOI 10.4045/tidsskr.10.1279, PubMed 21233875

Zeller B, Hellebostad M (2011)
H1N1 infection in children with haematological and oncological diseases in Norway
Acta Paediatr, 100 (8), 1134-7
DOI 10.1111/j.1651-2227.2011.02244.x, PubMed 21362035

Publications 2010

Abrahamsson J, Forestier E, Heldrup J, Jahnukainen K, Jónsson OG, Lausen B, Palle J, Zeller B, Hasle H (2010)
Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate
J Clin Oncol, 29 (3), 310-5
DOI 10.1200/JCO.2010.30.6829, PubMed 21149663

Publications 2009

Bohnstedt C, Taskinen M, Zeller B, Björgvinsdóttir H, Hafsteinsdottir S, Schmiegelow K (2009)
Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia
J Pediatr Hematol Oncol, 31 (1), 79-80
DOI 10.1097/MPH.0b013e31818b37a9, PubMed 19125098

Publications 2007

Abrahamsson J, Clausen N, Gustafsson G, Hovi L, Jonmundsson G, Zeller B, Forestier E, Heldrup J, Hasle H, Nordic Society for Paediatric Haematology and Oncology (NOPHO) (2007)
Improved outcome after relapse in children with acute myeloid leukaemia
Br J Haematol, 136 (2), 229-236
DOI 10.1111/j.1365-2141.2006.06419.x, PubMed 17278259

Edslev PW, Rosthøj S, Treutiger I, Rajantie J, Zeller B, Jonsson OG, NOPHO ITP Working Group (2007)
A clinical score predicting a brief and uneventful course of newly diagnosed idiopathic thrombocytopenic purpura in children
Br J Haematol, 138 (4), 513-6
DOI 10.1111/j.1365-2141.2007.06682.x, PubMed 17608764

Hasle H, Abrahamsson J, Arola M, Karow A, O'Marcaigh A, Reinhardt D, Webb DK, van Wering E, Zeller B, Zwaan CM, Vyas P (2007)
Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML
Leukemia, 22 (7), 1428-30
DOI 10.1038/sj.leu.2405060, PubMed 18059480

Kolmannskog S, Flaegstad T, Helgestad J, Hellebostad M, Zeller B, Glomstein A (2007)
[Childhood acute lymphoblastic leukemia in Norway 1992-2000]
Tidsskr Nor Laegeforen, 127 (11), 1493-5
PubMed 17551551

Norton A, Fisher C, Liu H, Wen Q, Mundschau G, Fuster JL, Hasle H, Zeller B, Webb DK, O'Marcaigh A, Sorrell A, Hilden J, Gamis A, Crispino JD, Vyas P (2007)
Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome
Blood, 110 (3), 1077-9
DOI 10.1182/blood-2007-03-080374, PubMed 17644747

Treutiger I, Rajantie J, Zeller B, Henter JI, Elinder G, Rosthøj S, NOPHO ITP Study Group (2007)
Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?
Arch Dis Child, 92 (8), 704-7
DOI 10.1136/adc.2006.098442, PubMed 17460024

Zeller B (2007)
[Something to learn from--not only for the pediatricians]
Tidsskr Nor Laegeforen, 127 (7), 886
PubMed 17441227

Publications 2006

Abildgaard L, Ellebaek E, Gustafsson G, Abrahamsson J, Hovi L, Jonmundsson G, Zeller B, Hasle H (2006)
Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature
Ann Hematol, 85 (5), 275-80
DOI 10.1007/s00277-005-0045-5, PubMed 16518605

Rajantie J, Zeller B, Treutiger I, Rosthöj S, NOPHO ITP working group and five national study groups (2006)
Vaccination associated thrombocytopenic purpura in children
Vaccine, 25 (10), 1838-40
DOI 10.1016/j.vaccine.2006.10.054, PubMed 17126957

Treutiger I, Rajantie J, Zeller B, Elinder G, Rosthöj S, NOPHO ITP Working Group (2006)
Initial management of children with newly diagnosed idiopathic thrombocytopenic purpura in the Nordic countries
Acta Paediatr, 95 (6), 726-31
DOI 10.1080/08035250500486660, PubMed 16754555

Publications 2005

Christensen MS, Heyman M, Möttönen M, Zeller B, Jonmundsson G, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2005)
Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001
Br J Haematol, 131 (1), 50-8
DOI 10.1111/j.1365-2141.2005.05736.x, PubMed 16173962

Lie SO, Abrahamsson J, Clausen N, Forestier E, Hasle H, Hovi L, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Zeller B, Gustafsson G, Nordic Society of Pediatric Hematology and Oncology (NOPHO), AML Study Group (2005)
Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials
Leukemia, 19 (12), 2090-100
DOI 10.1038/sj.leu.2403962, PubMed 16304571

Rosthøj S, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson OG, Henter JI (2005)
Age-dependent differences in Nordic children with ITP
J Pediatr, 146 (1), 151-2
DOI 10.1016/j.jpeds.2004.06.059, PubMed 15644852

Rosthøj S, Hedlund-Treutiger I, Rajantie J, Zeller B, Nordic Society for Paediatric Haematology and Oncology Idiopathic Thrombocytopenic Purpura Working Group (2005)
Factors predicting development of chronic disease in Nordic children with acute onset of idiopathic thrombocytopenic purpura
Br J Haematol, 130 (1), 148-9; author reply 150
DOI 10.1111/j.1365-2141.2005.05576.x, PubMed 15982360

Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J, Hovi L, Jonmundsson G, Lie SO, Glomstein A, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2005)
Acute leukaemia in children with Down syndrome: a population-based Nordic study
Br J Haematol, 128 (6), 797-804
DOI 10.1111/j.1365-2141.2005.05398.x, PubMed 15755283

Zeller B, Rajantie J, Hedlund-Treutiger I, Tedgård U, Wesenberg F, Jonsson OG, Henter JI, NOPHO ITP (2005)
Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease
Acta Paediatr, 94 (2), 178-84
DOI 10.1111/j.1651-2227.2005.tb01887.x, PubMed 15981751

Publications 2003

Rosthøj S, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson OG, Elinder G, Wesenberg F, Henter JI, NOPHO ITP Working Group (2003)
Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort
J Pediatr, 143 (3), 302-7
DOI 10.1067/s0022-3476(03)00245-2, PubMed 14517509

Publications 2002

Monclair T, Abeler VM, Kaern J, Walaas L, Zeller B, Hilstrøm C (2002)
Placental site trophoblastic tumor (PSTT) in mother and child: first report of PSTT in infancy
Med Pediatr Oncol, 38 (3), 187-91; discussion 192
DOI 10.1002/mpo.1308, PubMed 11836719

Publications 2001

Odland HH, Zeller B, Fjaerli HO, Zimmer O (2001)
[Acute pyelonephritis in children with minimal or normal urine findings]
Tidsskr Nor Laegeforen, 121 (27), 3166-9
PubMed 11876137

Publications 2000

Blom US, Zeller B, Perminow KV, Fjaerli HO (2000)
[Kawasaki disease]
Tidsskr Nor Laegeforen, 120 (29), 3540-3
PubMed 11188381

Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, Stensvold K, Wesenberg F (2000)
Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration
Pediatr Hematol Oncol, 17 (7), 551-8
DOI 10.1080/08880010050122816, PubMed 11033730

Zeller B, Storm-Mathisen I, Smevik B, Lie SO (2000)
Multisystem Langerhans-cell histiocytosis with life-threatening pulmonary involvement--good response to cyclosporine A
Med Pediatr Oncol, 35 (4), 438-42
DOI 10.1002/1096-911x(20001001)35:4<438::aid-mpo12>3.0.co;2-4, PubMed 11025480

Publications 1998

Zeller B, Bangstad HJ (1998)
[Accidental administration of racemic adrenaline. Three life-threatening cases after intravenous injection in children]
Tidsskr Nor Laegeforen, 118 (7), 1080-1
PubMed 9531834

Publications 1997

Zeller B (1997)
[Transient erythroblastopenia in children. Severe anemia with good prognosis]
Tidsskr Nor Laegeforen, 117 (22), 3201-4
PubMed 9411857

Zeller B, Storm-Mathisen I, Smevik B, Sund S, Danielsen K, Lie SO (1997)
Cure of infantile myofibromatosis with severe respiratory complications without antitumour therapy
Eur J Pediatr, 156 (11), 841-4
DOI 10.1007/s004310050725, PubMed 9392395

Publications 1996

Zeller B, Glomstein A, Wesenberg F (1996)
[Investigation and treatment of immune thrombocytopenic purpura in children in Norway]
Tidsskr Nor Laegeforen, 116 (18), 2157-9
PubMed 8801655

Zeller B, Lie SO (1996)
[Immune thrombocytopenic purpura in children--controversy and consensus. How much investigation and treatment is meaningful?]
Tidsskr Nor Laegeforen, 116 (18), 2160-4
PubMed 8801656

Publications 1995

Zeller B, Westvik J, Clausen OP, Selberg T (1995)
[Fibrodysplasia (myositis) ossificans progressiva]
Tidsskr Nor Laegeforen, 115 (28), 3496-8
PubMed 7491602

Page visits: 323